These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16187237

  • 1. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
    Guo BL, Liu Z, Aldrich WA, Lopez RD.
    Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
    [Abstract] [Full Text] [Related]

  • 2. Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitro.
    Liu Z, Guo BL, Gehrs BC, Nan L, Lopez RD.
    J Urol; 2005 May; 173(5):1552-6. PubMed ID: 15821484
    [Abstract] [Full Text] [Related]

  • 3. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
    Liu Z, Guo B, Lopez RD.
    J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
    [Abstract] [Full Text] [Related]

  • 4. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008 May; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 5. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N, Narita M, Yokoyama A, Sekiguchi A, Saito A, Tochiki N, Furukawa T, Toba K, Aizawa Y, Takahashi M.
    Cytotherapy; 2006 May; 8(2):118-29. PubMed ID: 16698685
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M, Tanaka Y, Yagi J, Uchiyama T, Ogawa K.
    Anticancer Res; 2008 May; 28(5B):2921-31. PubMed ID: 19031935
    [Abstract] [Full Text] [Related]

  • 7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K, Frommer K, Meier S, Handgretinger R, Eyrich M.
    J Immunother; 2008 May; 31(9):896-905. PubMed ID: 18832998
    [Abstract] [Full Text] [Related]

  • 8. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
    Gaafar A, Aljurf MD, Al-Sulaiman A, Iqniebi A, Manogaran PS, Mohamed GE, Al-Sayed A, Alzahrani H, Alsharif F, Mohareb F, Ajarim D, Tabakhi A, Al-Hussein K.
    Exp Hematol; 2009 Jul; 37(7):838-48. PubMed ID: 19446661
    [Abstract] [Full Text] [Related]

  • 9. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.
    Rischer M, Pscherer S, Duwe S, Vormoor J, Jürgens H, Rossig C.
    Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953
    [Abstract] [Full Text] [Related]

  • 10. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D.
    Scand J Immunol; 2007 Aug; 66(2-3):320-8. PubMed ID: 17635809
    [Abstract] [Full Text] [Related]

  • 11. Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: A new approach.
    Dokouhaki P, Han M, Joe B, Li M, Johnston MR, Tsao MS, Zhang L.
    Cancer Lett; 2010 Nov 01; 297(1):126-36. PubMed ID: 20537791
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
    Devaud C, Bilhere E, Loizon S, Pitard V, Behr C, Moreau JF, Dechanet-Merville J, Capone M.
    Cancer Res; 2009 May 01; 69(9):3971-8. PubMed ID: 19383918
    [Abstract] [Full Text] [Related]

  • 15. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
    Iwasaki M, Tanaka Y, Kobayashi H, Murata-Hirai K, Miyabe H, Sugie T, Toi M, Minato N.
    Eur J Immunol; 2011 Feb 01; 41(2):345-55. PubMed ID: 21268005
    [Abstract] [Full Text] [Related]

  • 16. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
    Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F, Stassi G.
    J Immunol; 2009 Jun 01; 182(11):7287-96. PubMed ID: 19454726
    [Abstract] [Full Text] [Related]

  • 17. Perspectives of gammadelta T cells in tumor immunology.
    Kabelitz D, Wesch D, He W.
    Cancer Res; 2007 Jan 01; 67(1):5-8. PubMed ID: 17210676
    [Abstract] [Full Text] [Related]

  • 18. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
    Fisch P, Meuer E, Pende D, Rothenfusser S, Viale O, Kock S, Ferrone S, Fradelizi D, Klein G, Moretta L, Rammensee HG, Boon T, Coulie P, van der Bruggen P.
    Eur J Immunol; 1997 Dec 01; 27(12):3368-79. PubMed ID: 9464825
    [Abstract] [Full Text] [Related]

  • 19. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
    van der Veken LT, Hagedoorn RS, van Loenen MM, Willemze R, Falkenburg JH, Heemskerk MH.
    Cancer Res; 2006 Mar 15; 66(6):3331-7. PubMed ID: 16540688
    [Abstract] [Full Text] [Related]

  • 20. The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.
    Guzy C, Paclik D, Schirbel A, Sonnenborn U, Wiedenmann B, Sturm A.
    Int Immunol; 2008 Jul 15; 20(7):829-40. PubMed ID: 18448456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.